Gastrointestinal Medicine Manufacturer in India

WHO-GMP certified gastrointestinal medicine manufacturing — PPIs, antacids, antispasmodics, antiemetics, laxatives and antidiarrhoeals across tablets, capsules, syrups, suspensions and sterile injections for domestic supply, institutional procurement and international export.

Key Highlights

WHO-GMP
Certified Facility
PPIs · Antacids
· Antiemetics · GI Range
15+ Countries
Supplied
DCGI Approved
Formulations

Request A Product List

Download Capability Brochure

About Gastrointestinal

Gastrointestinal medicine manufacturing expertise at 9M India

9M India manufactures a comprehensive range of gastrointestinal medicines from a WHO-GMP certified facility in Birkoni, Chhattisgarh. Our GI portfolio covers the full spectrum of gastrointestinal therapeutic categories — Proton Pump Inhibitors (PPIs), antacids and antireflux agents, antiemetics, antispasmodics, laxatives, antidiarrhoeals and digestive enzymes — across tablets, capsules, syrups, suspensions, oral solutions and sterile injectable formulations.

Gastrointestinal medicines are among the highest-volume medicine categories in both domestic and export markets. Pantoprazole and Omeprazole — as standard and enteric-coated tablets and injectable formulations — are core items in every hospital formulary and government tender programme. Ondansetron across oral and injectable formats represents one of the most demanded antiemetic molecules in institutional supply globally.

The manufacturing complexity of GI medicines spans enteric-coated tablet technology (PPIs require protection from gastric acid), antacid suspension manufacturing (physical stability and neutralising capacity), antiemetic oral dissolving tablet technology and sterile PPI injectable manufacturing. 9M India's manufacturing capability addresses every level of this complexity.

GI medicines across PPIs, antacids, antiemetics, laxatives, antidiarrhoeals, digestive enzymes
Enteric-coated PPI tablets, antacid suspensions, antiemetic ODTs and sterile PPI injections
Pantoprazole, Omeprazole, Ondansetron, Domperidone, Metoclopramide
WHO-GMP certified with in-house enteric coat dissolution testing
DCGI-approved — export-ready with complete documentation

Enquire Now

Our Capabilities

Gastrointestinal medicine manufacturing capabilities at 9M India

01

Pantoprazole enteric-coated tablets (20mg and 40mg) — the most widely prescribed PPI globally, core to every hospital formulary and government tender list. Omeprazole enteric- coated capsules (20mg and 40mg) — acid-labile API encapsulated as enteric-coated pellets in hard gelatin capsules. Lansoprazole delayed-release capsules. PPI manufacturing requires protection of the acid-labile active from gastric pH during manufacturing, coating and packaging — enteric-coated pellet and tablet technology with validated acid resistance (2-hour acid stage) and dissolution in pH 6.8 buffer confirming release in simulated intestinal fluid.
02

Aluminium hydroxide + Magnesium hydroxide combination antacid suspensions — formulated for appropriate acid-neutralising capacity, physical stability against settling and acceptable palatability. Sodium bicarbonate oral solution and powder preparations. Antacid tablet formulations for rapid neutralisation. Antacid + simethicone combination suspensions for flatulence and GI discomfort. Physical stability testing — sedimentation rate, resuspendability and viscosity — monitored throughout shelf life for all antacid suspension formulations.
03

Ondansetron tablets (4mg, 8mg), Ondansetron ODT (orally dissolving tablets) and Ondansetron oral solution — the most widely used antiemetic in institutional supply. Ondansetron injection (vial liquid, 2mg/mL) — sterile injectable antiemetic manufactured under classified cleanroom conditions. Domperidone tablets and suspension — prokinetic antiemetic. Metoclopramide tablets and injection. Antiemetic ODT manufacturing requires validated disintegration performance and in-mouth palatability as primary quality attributes.
04

Lactulose oral solution and syrup (osmotic laxative) — high-volume institutional formulary item for hepatic encephalopathy and constipation. Loperamide tablets (antidiarrhoeal). Bisacodyl enteric-coated tablets (stimulant laxative). Ispaghula husk granules and powder (bulk- forming laxative — sachet format). Sucralfate suspension (gastric mucosal protective agent). These formulations span the range of GI preparations most frequently tendered in government health programmes and NHM supply.
05

Pantoprazole injection (dry powder for injection — 40mg vials) and Omeprazole injection — sterile injectable PPI formulations for hospital critical care and surgical settings where oral administration is not feasible. Dry powder injectable manufacturing requires aseptic lyophilisation (freeze-drying) or aseptic dry powder filling under classified cleanroom conditions. Reconstitution instructions, compatibility with standard diluents and 24-hour post-reconstitution stability data are available for all PPI injectable formulations.

Dosage Forms

GI formulations across dosage forms

Tablets
- Enteric-coated
- Standard
- ODT
- Extended-release
- Pantoprazole
- Domperidone
- Loperamide
- Bisacodyl
Capsules
- Enteric-coated pellet capsules
- Hard gelatin
- Omeprazole
- Lansoprazole
Syrups & Suspensions
- Antacid suspension
- Antiemetic syrup
- Laxative syrup
- Aluminium + Magnesium hydroxide
- Ondansetron syrup
- Lactulose
- Domperidone
Oral Solutions
- Laxative solution
- Antacid solution
- Antiemetic solution
- Lactulose solution
- Ondansetron oral solution
- Sodium bicarbonate
Injections (Sterile)
- Dry powder
- Vial liquid
- Pantoprazole injection
- Ondansetron injection
- Methylprednisolone

Why Choose Us

Why choose 9M India for gastrointestinal
medicine manufacturing

Pantoprazole — tablet, capsule and sterile injectable. All formats. One manufacturer.

Pantoprazole enteric-coated tablets, Pantoprazole enteric-coated pellet capsules and Pantoprazole dry powder injection — all manufactured at 9M India. Single-source supply for the most prescribed GI medicine across every dosage form demanded in hospital and institutional settings.
Enteric-coat dissolution testing. In-house. Every batch.

PPI enteric-coated formulations require acid resistance validation (2-hour acid stage) and confirmed dissolution in pH 6.8 buffer — every batch. Our in-house analytical laboratory performs this testing as standard, with results documented in COA before batch release.
Antacid suspensions with validated physical stability.

Antacid suspensions settle during storage — what matters is resuspendability and dose uniformity after shaking. 9M India validates sedimentation rate, resuspendability and neutralising capacity per dose across shelf life. The formulation you ship performs the same as the formulation you tested.

Our Gastrointestinal Range

Key GI formulations manufactured at 9M India

01

Pantoprazole 40mg EC Tablet | GI | Enteric-coated | PPI
02

Omeprazole 20mg Capsule | GI | EC pellet capsule | PPI
03

Pantoprazole Injection | GI | Dry powder vial | PPI sterile injectable
04

Ondansetron 4mg Tablet | Antiemetic | Standard / ODT | 5-HT3 antagonist
05

Ondansetron Injection | Antiemetic | Vial liquid | 5-HT3 antagonist
06

Ondansetron Syrup | Antiemetic | Ready-to-use | 5-HT3 antagonist
07

Domperidone Tablet | Antiemetic | Standard tablet | Prokinetic
08

Al+Mg Hydroxide Suspension | Antacid | Suspension | Antacid combination
09

Lactulose Solution | Laxative | Oral solution | Osmotic laxative
10

Loperamide Tablet | Antidiarrhoeal | Standard tablet | Antidiarrhoeal
11

Sucralfate Suspension | Mucosal protective | Suspension | Gastric mucosal agent
12

Metoclopramide Injection | Antiemetic | Ampoule | Prokinetic

We keep answer short

Frequently asked questions —
gastrointestinal medicine manufacturing

01

PPIs (Pantoprazole, Omeprazole, Lansoprazole), antacids, antiemetics (Ondansetron, Domperidone, Metoclopramide), laxatives (Lactulose, Bisacodyl), antidiarrhoeals (Loperamide) and gastric mucosal agents (Sucralfate) — across tablets, capsules, syrups, suspensions, oral solutions and sterile injections.
02

Yes — Pantoprazole 40mg dry powder for injection in sterile vials, manufactured under classified cleanroom conditions. Reconstitution instructions, diluent compatibility and 24-hour post-reconstitution stability data available.
03

Yes — Pantoprazole enteric-coated tablets and Omeprazole enteric-coated pellet capsules. Acid resistance testing (2-hour acid stage) and dissolution in pH 6.8 buffer performed on every batch.
04

Yes — Pantoprazole, Ondansetron and Domperidone are core hospital formulary items. DCGI- approved with documentation pre-prepared for tender submission.
05

Yes — Aluminium hydroxide + Magnesium hydroxide combination antacid suspensions with validated neutralising capacity, physical stability and resuspendability across shelf life.